Sitemap
December 03, 2007 Articles
Filter by Available Specialty
- Alcon receives FDA approval for Triesence injectable triamcinolone suspension
- AMD patients switched from PDT to ranibizumab maintained visual acuity
- Baseline vision, central retinal thickness predictive of bevacizumab efficacy
- CMS final ruling issues a 10.1% cut for physicians; orthopedists may face more
- Ranibizumab shows continued safety, efficacy over longer-term follow-up